RxDoctor Payments Data

Whitney Eng

Pediatric Hematology-Oncology · Seattle, WANPI 1225371099

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,385 of the $7,696 with a category attached, or 96.0%. Servier Pharmaceuticals LLC accounts for 72.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $5,600 and has fallen 63.1% since, to $2,065 in 2025.

$7,696in general payments, 2019–2025

Across 7 payments — averaging $1099.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$6K
  • Novartis$2K
  • AbbVie$119
$675,598in research payments, 2019–2025

Across 8 payments — averaging $84,450 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$413K
  • Merck$263K

What the payments were for

  • Consulting fees$7,38596%
  • Food & beverage$3114%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Servier Pharmaceuticals LLC2$5,600
Novartis4$1,976
AbbVie1$119

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,696 in reported general payments places this provider in the 80th percentile of 60 pediatric hematology-oncology providers in Washington.

See all pediatric hematology-oncology providers in Washington

Other pediatric hematology-oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →